Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2011-08-23
2011-08-23
Kim, Jennifer M (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
active
08003701
ABSTRACT:
A method of treating or inhibiting, in particular, pain caused by inflammation in a mammal by administering to the mammal an effective inflammatory pain alleviating amount of a (1RS,3RS,6RS)-6-dimethyl-aminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol compound, preferably in the form of a physiologically acceptable salt, such as the hydrochloride.
REFERENCES:
patent: 4389393 (1983-06-01), Schor et al.
patent: 5330761 (1994-07-01), Baichwal
patent: 5399362 (1995-03-01), Baichwal et al.
patent: 5455046 (1995-10-01), Baichwal
patent: 5472711 (1995-12-01), Baichwal
patent: 5516803 (1996-05-01), Raffa
patent: 5733936 (1998-03-01), Buschmann et al.
patent: 6248737 (2001-06-01), Buschmann et al.
patent: 6673794 (2004-01-01), Puetz et al.
patent: 7022739 (2006-04-01), Buschmann et al.
patent: 7168937 (2007-01-01), Buschmann et al.
patent: 2002/0132825 (2002-09-01), Burch et al.
patent: 33 09 516 (1983-12-01), None
patent: 44 26 245 (1996-02-01), None
patent: 195 25 137 (1997-01-01), None
patent: 1 219 594 (2002-07-01), None
patent: WO 00 51685 (2000-09-01), None
patent: WO 01 49654 (2001-07-01), None
patent: WO 01/57232 (2001-08-01), None
patent: WO 02 28817 (2002-04-01), None
T. Issiouri et al., “The Efficacy of Premedication with Celecoxib and Acetaminophen in Preventing Pain After Otolaryngologic Surgery”, Anesth. Analg., May 2002, p. 1188, vol. 94.
Raymond Sinatra, MD, PHD, “Role of COX-2 Inhibitors in the Evolution of Acute Pain Management”, Journal of Pain and Symptom Management, Jul. 15, 2002, pp. S18-S27, vol. 24, No. 15, US Cancer Pain Relief Committee, Elsevier, New York, New York, USA.
German Office Action dated Oct. 23, 2003 (two (2) pages).
International Search Report dated Mar. 15, 2004 with English translation of relevant portions (seven (7) pages).
Le Bars, D. et al, “Animal Models of Nociception”,Pharmacol Rev., 53:597-652, 2001.
Abstract of Bannon, A.W. and Malmberg A.B., “Models of Nociception: Hot-Plate, Tail-Flick, and Formalin Tests In Rodents,”Curr. Prot. Neurosci., 41:8.9.1-8.9.16 (2007).
Negus, S.S., Vanderah, T.W., Brandt, M.R., Bilsky, E.J., Becerra, L., Borsook, D., “Preclinical assessment of candidate analgesic drugs: recent advances and future challenges,” Review,J. Pharmacol. Exp. Ther., Nov; 319(2):507-14 (2006) [E-published Jun. 2, 2006].
Huidobro, F, Huidobro-Toro, J.P., Leong, Way E., “Studies on tolerance development to single doses of morphine in mice, ”J. Pharmacol. Exp. Ther., Aug; 198(2):318-29 (1976).
D'Amour, F.E. and Smith, D.L “A method for determining loss of pain sensation,”J. Pharmacol. Exp. Ther., 72:74-78 (1941).
Randall, L.O. and Selitto, J.J., “A method for measurement of analgesic activity on inflamed tissue,”Arch. Int. Pharmacodyn. Ther. Sep., 1111(4):409-19 (1957).
Friderichs Elmar
Haase Guenther
Jahnel Ulrich
Koegel Babette-Yvonne
Schiene Klaus
Crowell & Moring LLP
Gruenenthal GmbH
Kim Jennifer M
LandOfFree
Method of inhibiting inflammatory pain does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting inflammatory pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting inflammatory pain will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2712963